Home
>
National Drug Code (NDC)
>
Risperidone
Risperidone - 0093-0225-05 - (Risperidone)
Drug Information of Risperidone
| Product NDC: | 0093-0225 |
| Proprietary Name: | Risperidone |
| Non Proprietary Name: | Risperidone |
| Active Ingredient(s): | .5 mg/1 & nbsp; Risperidone |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Risperidone
| Product NDC: | 0093-0225 |
| Labeler Name: | Teva Pharmaceuticals USA Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076228 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20080630 |
Package Information of Risperidone
| Package NDC: | 0093-0225-05 |
| Package Description: | 500 TABLET, FILM COATED in 1 BOTTLE (0093-0225-05) |
NDC Information of Risperidone
| NDC Code | 0093-0225-05 |
| Proprietary Name | Risperidone |
| Package Description | 500 TABLET, FILM COATED in 1 BOTTLE (0093-0225-05) |
| Product NDC | 0093-0225 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Risperidone |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20080630 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Pharmaceuticals USA Inc |
| Substance Name | RISPERIDONE |
| Strength Number | .5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Atypical Antipsychotic [EPC] |
